DRUG STUDY

Date Generic Brand Classificatio Indication Mechanis Dosage & Time Adverse Nursing
Name Name n m of Action Frequency Given Reaction Consideration
03-11- Ketorolac Toradol Nonsteroida Short Inhibit 1 amp CNS: -Assess the pt
21 l anti- term prostaglan IVTT q 8 Headache, before
inflammator managem din prn for dizziness, administering the
y drugs ent of synthesis pain drowsiness, drug: know the
(NSAIDs), moderatel anti- sedation, history (e.g.
nonopoid y severe, inflammato insomia allergies, renal
analgesics acute ry, Respiratory: impairment, etc)
pain. analgesics, Rhinitis, and physical
and hemoptysis, condition of pt.
antipyretic dyspnea (reflexes,
effects GI: ophthalmologic
GI pain, and audiometric
diarrhea, evaluation,
vomiting, orientation, clotting
nausea times, serum
Hematologic: electrolyctes).
Neutropenia, -In case of
leukopenia, hypersensitivity,
Decrease be sure that
Hgb or Hct, emergency
bone marrow equipment is
depression available.
Dermacologic
: -Drug vials should
Sweating, dry be protected from
mucous the light.
membrane,
pruritus -Report any signs
of itching, swelling
in the ankles, sore
throat, easy
bruising, etc.)